tradingkey.logo
tradingkey.logo
Search

Avanos Medical Inc

AVNS
Add to Watchlist
24.710USD
+0.010+0.04%
Close 05/15, 16:00ETQuotes delayed by 15 min
1.16BMarket Cap
LossP/E TTM

Avanos Medical Inc

24.710
+0.010+0.04%

More Details of Avanos Medical Inc Company

Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. It also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.

Avanos Medical Inc Info

Ticker SymbolAVNS
Company nameAvanos Medical Inc
IPO dateOct 21, 2014
CEOPacitti (David)
Number of employees2227
Security typeOrdinary Share
Fiscal year-endOct 21
Address5405 Windward Parkway
CityALPHARETTA
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code30004
Phone18444282667
Websitehttps://avanos.com/
Ticker SymbolAVNS
IPO dateOct 21, 2014
CEOPacitti (David)

Company Executives of Avanos Medical Inc

Name
Name/Position
Position
Shareholding
Change
Mr. David Pacitti
Mr. David Pacitti
Chief Executive Officer, Director
Chief Executive Officer, Director
564.24K
-3.76%
Mr. Gary D. Blackford
Mr. Gary D. Blackford
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
131.59K
+30.40%
Mr. Sigfrido (Sig) Delgado
Mr. Sigfrido (Sig) Delgado
Senior Vice President - Integrated Supply Chain
Senior Vice President - Integrated Supply Chain
76.17K
-5.60%
Mr. Patrick J. O'Leary
Mr. Patrick J. O'Leary
Independent Director
Independent Director
66.64K
--
Dr. Julie Ann Shimer, Ph.D.
Dr. Julie Ann Shimer, Ph.D.
Independent Director
Independent Director
62.09K
--
Dr. Lisa C. Egbuonu-Davis, M.D.
Dr. Lisa C. Egbuonu-Davis, M.D.
Independent Director
Independent Director
--
--
Ms. Indrani L. Franchini, J.D.
Ms. Indrani L. Franchini, J.D.
Independent Director
Independent Director
--
--
Mr. Jason M. Pickett
Mr. Jason M. Pickett
Vice President - Corporate Finance, Treasurer
Vice President - Corporate Finance, Treasurer
--
--
Ms. Camille Chang Gilmore
Ms. Camille Chang Gilmore
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
--
--
Mr. Scott Galovan
Mr. Scott Galovan
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. David Pacitti
Mr. David Pacitti
Chief Executive Officer, Director
Chief Executive Officer, Director
564.24K
-3.76%
Mr. Gary D. Blackford
Mr. Gary D. Blackford
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
131.59K
+30.40%
Mr. Sigfrido (Sig) Delgado
Mr. Sigfrido (Sig) Delgado
Senior Vice President - Integrated Supply Chain
Senior Vice President - Integrated Supply Chain
76.17K
-5.60%
Mr. Patrick J. O'Leary
Mr. Patrick J. O'Leary
Independent Director
Independent Director
66.64K
--
Dr. Julie Ann Shimer, Ph.D.
Dr. Julie Ann Shimer, Ph.D.
Independent Director
Independent Director
62.09K
--
Dr. Lisa C. Egbuonu-Davis, M.D.
Dr. Lisa C. Egbuonu-Davis, M.D.
Independent Director
Independent Director
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Digestive Health
432.90M
61.74%
Pain Management
268.30M
38.26%
By RegionUSD
Name
Revenue
Proportion
North America
543.90M
77.57%
Europe, Middle East and Africa
102.80M
14.66%
Asia Pacific and Latin America
54.50M
7.77%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Digestive Health
432.90M
61.74%
Pain Management
268.30M
38.26%

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.17%
Armistice Capital LLC
6.83%
Dimensional Fund Advisors, L.P.
4.38%
Vanguard Capital Management, LLC
4.21%
State Street Investment Management (US)
4.17%
Other
67.23%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.17%
Armistice Capital LLC
6.83%
Dimensional Fund Advisors, L.P.
4.38%
Vanguard Capital Management, LLC
4.21%
State Street Investment Management (US)
4.17%
Other
67.23%
Shareholder Types
Shareholders
Proportion
Investment Advisor
40.43%
Investment Advisor/Hedge Fund
28.87%
Hedge Fund
17.30%
Individual Investor
4.78%
Research Firm
2.86%
Family Office
2.12%
Pension Fund
1.27%
Bank and Trust
0.48%
Insurance Company
0.03%
Other
1.87%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
605
45.51M
97.19%
-9.79M
2025Q4
599
44.88M
113.89%
+5.76K
2025Q3
617
45.01M
114.39%
-81.05K
2025Q2
610
45.14M
115.30%
+1.07M
2025Q1
615
44.04M
105.94%
-4.70M
2024Q4
596
44.47M
105.92%
+325.84K
2024Q3
583
44.12M
104.92%
+568.23K
2024Q2
585
43.69M
107.04%
-931.37K
2024Q1
593
44.72M
107.68%
-5.03M
2023Q4
601
45.14M
107.42%
+359.77K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
6.17M
13.26%
+18.95K
+0.31%
Dec 31, 2025
Armistice Capital LLC
3.20M
6.88%
+700.00K
+28.00%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
2.16M
4.64%
-195.10K
-8.29%
Dec 31, 2025
State Street Investment Management (US)
1.95M
4.2%
+53.52K
+2.82%
Dec 31, 2025
Brown Advisory
1.94M
4.16%
-290.95K
-13.07%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
4.47M
9.61%
-242.87K
-5.15%
Dec 31, 2025
D. E. Shaw & Co., L.P.
1.21M
2.6%
-88.59K
-6.82%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
State Street SPDR S&P Health Care Equipment ETF
0.8%
Invesco S&P SmallCap 600 Pure Value ETF
0.43%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.37%
Invesco S&P SmallCap Health Care ETF
0.32%
Royce Quant Small-Cap Quality Value ETF
0.31%
Harbor Human Capital Factor US Small Cap ETF
0.22%
Vanguard US Value Factor ETF
0.15%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.13%
Fidelity Enhanced Small Cap ETF
0.13%
Pacer US Small Cap Cash Cows ETF
0.09%
View more
State Street SPDR S&P Health Care Equipment ETF
Proportion0.8%
Invesco S&P SmallCap 600 Pure Value ETF
Proportion0.43%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proportion0.37%
Invesco S&P SmallCap Health Care ETF
Proportion0.32%
Royce Quant Small-Cap Quality Value ETF
Proportion0.31%
Harbor Human Capital Factor US Small Cap ETF
Proportion0.22%
Vanguard US Value Factor ETF
Proportion0.15%
SPDR SSGA US Small Cap Low Volatility Index ETF
Proportion0.13%
Fidelity Enhanced Small Cap ETF
Proportion0.13%
Pacer US Small Cap Cash Cows ETF
Proportion0.09%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI